Bovine Parainfluenza Virus (BPIV-3) is a viral agent of great importance to the cattle industry, primarily associated with respiratory diseases in cattle. The virus belongs to the Paramyxoviridae family, genus Respirovirus, and is recognized as one of the main components of the Bovine Respiratory Complex (BRC), responsible for significant production losses in herds.
BPIV-3 infection occurs most frequently in calves and young animals, although cattle of all ages can be affected. Clinical signs include fever, nasal discharge, coughing, dyspnea, and lethargy. In many cases, primary infection with the virus predisposes animals to secondary bacterial infections, worsening respiratory symptoms.
The virus exhibits tropism for the respiratory tract, where it replicates in epithelial cells, causing tissue damage and compromising local defense mechanisms. The immunosuppression induced by BPIV-3 facilitates the establishment of opportunistic pathogens, contributing to increased clinical severity and mortality associated with Bovine Respiratory Complex.
Bovine parainfluenza virus is transmitted primarily through the respiratory tract, via aerosols and nasal secretions from infected animals. Stressful situations, such as transport, crowding, weaning, and sudden changes in management practices, increase the animals’ susceptibility and facilitate the spread of the virus within herds.
The economic impacts associated with BPIV-3 infection include reduced weight gain, increased veterinary treatment costs, higher morbidity and mortality rates, as well as indirect losses resulting from a decline in the animals’ zootechnical performance.
The prevention and control of BPIV-3 rely on the implementation of integrated biosecurity and disease management measures. Vaccination is widely used as a preventive tool, especially in programs to control the Bovine Respiratory Complex, helping to reduce clinical severity and viral spread.
Laboratory diagnosis of Bovine Parainfluenza Virus can be performed using serological and molecular methods, such as RT-PCR, which allow for the detection of viral genetic material with high sensitivity. Early diagnosis is essential for implementing control measures and for the proper management of respiratory outbreaks.
Continuous epidemiological surveillance, combined with the implementation of vaccination programs, good management practices, and biosecurity measures, is essential for reducing the circulation of BPIV-3 in herds. These measures contribute to improving animal health, reducing economic losses, and strengthening the sustainability of the beef production chain.
*]:pointer-events-auto scroll-mt-[calc(var(–header-height)+min(200px,max(70px,20svh)))]” dir=”auto” tabindex=”-1″ data-turn-id=”request-WEB:fe9b6517-792e-400f-9654-1c43d01eef55-32″ data-testid=”conversation-turn-66″ data-scroll-anchor=”true” data-turn=”assistant”>
In this context, Bioperfectus’ rapid test for Bovine Parainfluenza Virus type 3 (BPIV-3) serves as a practical screening tool to support disease surveillance in cattle herds. The use of the rapid test allows for the rapid identification of suspect animals directly in the field, especially during respiratory outbreaks, facilitating the immediate implementation of measures such as herd isolation, adjustments to management practices, enhanced biosecurity, and the submission of samples for confirmation via laboratory methods. Thus, the rapid test complements molecular diagnosis, contributing to the early detection of BPIV-3, the reduction of viral spread, and the strengthening of control strategies for the Bovine Respiratory Complex.
